CHRAC1 sirna
CHRAC1 siRNA (Human)
Gene Names
CHRAC1; YCL1; CHARC1; CHARC15; CHRAC-1; CHRAC15; CHRAC-15
Reactivity
Human
Applications
RNA Interference (RNAi)
Purity
> 97%
Synonyms
CHRAC1; CHRAC1 siRNA (Human); CHRAC15; Chromatin accessibility complex protein 1; CHRAC-1; Chromatin accessibility complex 15 kDa protein; CHRAC-15; HuCHRAC15; DNA polymerase epsilon subunit p15; CHRAC1 sirna
Host
Synthetic
Reactivity
Human
Specificity
CHRAC1 siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
Purity/Purification
> 97%
Form/Format
Lyophilized powder
Sequence Length
131
Applicable Applications for CHRAC1 sirna
RNA Interference (RNAi)
Quality Control
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use
We recommends transfection with 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For each vial, suitable for 250 transfections in 24 well plate (20 pmol for each well).
Components
We offer pre-designed sets of 3 different target-specific siRNA oligo duplexes of human CHRAC1 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2'-OMe) at no extra charge for increased stability and enhanced knockdown in vitro and in vivo.
Preparation and Storage
Shipped at 4 degree C. Store at -20 degree C for one year.
Related Product Information for CHRAC1 sirna
siRNA to inhibit CHRAC1 expression using RNA interference
NCBI and Uniprot Product Information
NCBI GI #
NCBI GeneID
NCBI Accession #
NCBI GenBank Nucleotide #
UniProt Accession #
Molecular Weight
14,711 Da
NCBI Official Full Name
chromatin accessibility complex protein 1
NCBI Official Synonym Full Names
chromatin accessibility complex 1
NCBI Official Symbol
CHRAC1
NCBI Official Synonym Symbols
YCL1; CHARC1; CHARC15; CHRAC-1; CHRAC15; CHRAC-15
NCBI Protein Information
chromatin accessibility complex protein 1
UniProt Protein Name
Chromatin accessibility complex protein 1
Protein Family
UniProt Gene Name
CHRAC1
UniProt Synonym Gene Names
CHRAC15; CHRAC-1; CHRAC-15; HuCHRAC15
UniProt Entry Name
CHRC1_HUMAN
NCBI Description
CHRAC1 is a histone-fold protein that interacts with other histone-fold proteins to bind DNA in a sequence-independent manner. These histone-fold protein dimers combine within larger enzymatic complexes for DNA transcription, replication, and packaging.[supplied by OMIM, Apr 2004]
Uniprot Description
CHRAC1: Forms a complex with DNA polymerase epsilon subunit POLE3 and binds naked DNA, which is then incorporated into chromatin, aided by the nucleosome remodeling activity of ISWI/SNF2H and ACF1.
Protein type: DNA-binding
Chromosomal Location of Human Ortholog: 8q24.3
Cellular Component: epsilon DNA polymerase complex; chromatin accessibility complex
Molecular Function: DNA binding; protein heterodimerization activity; sequence-specific DNA binding; DNA-directed DNA polymerase activity
Biological Process: chromatin remodeling
Research Articles on CHRAC1
Similar Products
Product Notes
The CHRAC1 chrac1 (Catalog #AAA8238150) is a siRNA produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase. The CHRAC1 siRNA (Human) reacts with Human and may cross-react with other species as described in the data sheet. AAA Biotech's CHRAC1 can be used in a range of immunoassay formats including, but not limited to, RNA Interference (RNAi). Researchers should empirically determine the suitability of the CHRAC1 chrac1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "CHRAC1, siRNA" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
